Ignite Creation Date:
2025-12-25 @ 2:05 AM
Ignite Modification Date:
2026-01-26 @ 1:21 AM
Study NCT ID:
NCT05442060
Status:
RECRUITING
Last Update Posted:
2025-08-03
First Post:
2022-06-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
To Evaluate OBI-833/OBI-821 in Combination With First-Line Erlotinib in Patients With EGFR-Mutated, Globo H-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Sponsor:
Organization: